| Home | E-Submission | Sitemap | Editorial Office |  
top_img
    
REVIEW ARTICLE 2023 October 5
Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor–Positive Breast Cancer
Hormone receptor–positive (HR+) disease is the most frequently diagnosed subtype of breast cancer. Among tumor subtypes, natural course of HR+ breast cancer is indolent with favorable prognosis compared to other subtypes such as human epidermal growth factor protein 2–positiv...
ORIGINAL ARTICLE 2023 June 12
Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients
Purpose Patient-derived tumor cells can be a powerful resource for studying pathophysiological mechanisms and developing robust strategies for precision medicine. However, establishing organoids from patient-derived cells is challenging because of limited access to tissue specim...
ORIGINAL ARTICLE 2023 June 15
Clinicopathological Characteristics of NRG1 Fusion–Positive Solid Tumors in Korean Patients
Purpose Neuregulin 1 (NRG1) gene fusion is a potentially actionable oncogenic driver. The oncoprotein binds to ERBB3-ERBB2 heterodimers and activates downstream signaling, supporting a therapeutic approach for inhibiting ERBB3/ERBB2. However, the frequency and clinicopathologica...
ORIGINAL ARTICLE 2023 April 7
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy
Purpose Several previous studies and case reports have reported ethanol-induced symptoms in patients receiving anticancer drugs containing ethanol. Most docetaxel formulations contain ethanol as a solvent. However, there are insufficient data on ethanol-induced symptoms when doc...
Current Issue
Volume 55(4); Oct 2023
Volume 55(3); July 2023
Volume 55(2); April 2023
RSS feed
  • Most-read are based on citations from 2021 ~ 2023.
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018 ( 16067 times )
    Seri Hong, Young-Joo Won, Jae Jun Lee, Kyu-Won Jung, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2021;53(2):301-315.   Published online March 17, 2021    DOI: https://doi.org/10.4143/crt.2021.291
                            Supplementary         Cited By 207
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019 ( 15722 times )
    Mee Joo Kang, Young-Joo Won, Jae Jun Lee, Kyu-Won Jung, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2022;54(2):330-344.   Published online March 16, 2022    DOI: https://doi.org/10.4143/crt.2022.128
                            Supplementary         Cited By 129
    Pediatric cancer
    Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAFV600E-Mutated Langerhans Cell Histiocytosis ( 14788 times )
    Ying Yang, Dong Wang, Lei Cui, Hong-Hao Ma, Li Zhang, Hong-Yun Lian, Qing Zhang, Xiao-Xi Zhao, Li-Ping Zhang, Yun-Ze Zhao, Na Li, Tian-You Wang, Zhi-Gang Li, Rui Zhang
    Cancer Res Treat. 2021;53(1):261-269.   Published online September 15, 2020    DOI: https://doi.org/10.4143/crt.2020.769
                            Supplementary         Cited By 12
    Prediction of Cancer Incidence and Mortality in Korea, 2021 ( 10866 times )
    Kyu-Won Jung, Young-Joo Won, Seri Hong, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
    Cancer Res Treat. 2021;53(2):316-322.   Published online March 17, 2021    DOI: https://doi.org/10.4143/crt.2021.290
                               Cited By 58
    Prediction of Cancer Incidence and Mortality in Korea, 2022 ( 9936 times )
    Kyu-Won Jung, Young-Joo Won, Mee Joo Kang, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
    Cancer Res Treat. 2022;54(2):345-351.   Published online March 21, 2022    DOI: https://doi.org/10.4143/crt.2022.179
                               Cited By 28
    Immunotherapy
    The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients ( 9304 times )
    Si-Qi Tang, Ling-Long Tang, Yan-Ping Mao, Wen-Fei Li, Lei Chen, Yuan Zhang, Ying Guo, Qing Liu, Ying Sun, Cheng Xu, Jun Ma
    Cancer Res Treat. 2021;53(2):339-354.   Published online November 6, 2020    DOI: https://doi.org/10.4143/crt.2020.790
                            Supplementary         Cited By 51
    Head and Neck Cancer
    Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma ( 9304 times )
    Wan-Ru Zhang, Yu-Yun Du, Chun-Yan Guo, Han-Xing Zhou, Jie-Yi Lin, Xiao-Han Meng, Hao-Yuan Mo, Dong-Hua Luo
    Cancer Res Treat. 2021;53(4):991-1003.   Published online January 13, 2021    DOI: https://doi.org/10.4143/crt.2020.1298
                            
    Basic
    TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis ( 9183 times )
    Kyungsoo Jung, Joon-Seok Choi, Beom-Mo Koo, Yu Jin Kim, Ji-Young Song, Minjung Sung, Eun Sol Chang, Ka-Won Noh, Sungbin An, Mi-Sook Lee, Kyoung Song, Hannah Lee, Ryong Nam Kim, Young Kee Shin, Doo-Yi Oh, Yoon-La Choi
    Cancer Res Treat. 2021;53(1):9-24.   Published online September 16, 2020    DOI: https://doi.org/10.4143/crt.2020.434
                            Supplementary         Cited By 8
    Breast Cancer
    Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer ( 8415 times )
    Erwin Danil Yulian, Nurjati Chairani Siregar, Bajuadji
    Cancer Res Treat. 2021;53(4):1072-1083.   Published online March 9, 2021    DOI: https://doi.org/10.4143/crt.2020.1024
                               Cited By 14
    Practical Advice for South Korean Medical Researchers Regarding Open-Access and Predatory Journals ( 8309 times )
    Chai Hong Rim
    Cancer Res Treat. 2021;53(1):1-8.   Published online September 21, 2020    DOI: https://doi.org/10.4143/crt.2020.816
                            Supplementary         Cited By 1
    Korean Cancer Association
    E-Submission
    EndNote Output Style
    Email Alert
    Journal Impact Factor 4.6
    SCImago Journal & Country Rank
    PubMed Central
    MEDLINE/PubMed
    Scopus
    KoreaMed
    KoMCI
    ScienceCentral
    GoogleScholar
    Similarity Check
    Crossref Cited-by Linking
    CrossMark
    Funder Registry
    Metadata
    ORCID
    COPE
    Editorial Office
    Korean Cancer Association
    Room 1824, Gwanghwamun Officia
    92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
    TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © Korean Cancer Association.                 Developed in M2PI